RE: Thermo-Fisher relationship looks strong. Update and 10p+19 Mar 2025 13:50
Agreed. Singer are forecasting $11m revs for 2025, and still having positive cash balances by the end of 2025. True they're the house broker so take their forecast with a modest pinch of salt, but at $3000 a pop for Tutivia (our CEO says that they had underestimated how many tests would be used post-op), and more milestone payments from Thermo Fisher still to come, I don't think it's unrealistic at all. Monthly breakeven could easily come in mid-2026 IMO, and we won't be at a ridiculous 2p by then :-)
Look how quickly the SP trebled just a few months ago, on relatively modest volume...
No advice intended etc